Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1975 1
1983 1
1984 4
1985 5
1986 2
1987 3
1988 5
1989 5
1990 3
1991 7
1992 5
1993 5
1994 4
1995 6
1996 5
1997 3
1998 3
1999 2
2001 2
2002 4
2003 3
2004 5
2005 2
2006 4
2007 6
2008 4
2009 1
2010 3
2011 6
2012 2
2013 4
2014 9
2015 4
2016 7
2017 7
2018 8
2019 6
2020 5
2021 11
2022 13
2023 15
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

184 results

Results by year

Filters applied: . Clear all
Page 1
Phase II Trial of Atezolizumab Combined With Carboplatin and Pemetrexed for Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer With Untreated Brain Metastases (Atezo-Brain, GECP17/05).
Nadal E, Rodríguez-Abreu D, Simó M, Massutí B, Juan O, Huidobro G, López R, De Castro J, Estival A, Mosquera J, Sullivan I, Felip E, Blasco A, Guirado M, Pereira E, Vilariño N, Navarro V, Bruna J. Nadal E, et al. Among authors: sullivan i. J Clin Oncol. 2023 Oct 1;41(28):4478-4485. doi: 10.1200/JCO.22.02561. Epub 2023 Aug 21. J Clin Oncol. 2023. PMID: 37603816 Free PMC article. Clinical Trial.
Atezolizumab Plus Bevacizumab as First-line Treatment for Patients With Metastatic Nonsquamous Non-Small Cell Lung Cancer With High Tumor Mutation Burden: A Nonrandomized Controlled Trial.
Provencio M, Ortega AL, Coves-Sarto J, Calvo V, Marsé-Fabregat R, Dómine M, Guirado M, Carcereny E, Fernández N, Álvarez R, Blanco R, León-Mateos L, Sánchez-Torres JM, Sullivan IG, Cobo M, Sánchez-Hernández A, Massuti B, Sierra-Rodero B, Mártinez-Toledo C, Serna-Blasco R, Romero A, Cruz-Bermúdez A. Provencio M, et al. Among authors: sullivan ig. JAMA Oncol. 2023 Mar 1;9(3):344-353. doi: 10.1001/jamaoncol.2022.5959. JAMA Oncol. 2023. PMID: 36520426 Free PMC article.
BID expression determines the apoptotic fate of cancer cells after abrogation of the spindle assembly checkpoint by AURKB or TTK inhibitors.
Bertran-Alamillo J, Giménez-Capitán A, Román R, Talbot S, Whiteley R, Floc'h N, Martínez-Pérez E, Martin MJ, Smith PD, Sullivan I, Terp MG, Saeh J, Marino-Buslje C, Fabbri G, Guo G, Xu M, Tornador C, Aguilar-Hernández A, Reguart N, Ditzel HJ, Martínez-Bueno A, Nabau-Moretó N, Gascó A, Rosell R, Pease JE, Polanska UM, Travers J, Urosevic J, Molina-Vila MA. Bertran-Alamillo J, et al. Among authors: sullivan i. Mol Cancer. 2023 Jul 13;22(1):110. doi: 10.1186/s12943-023-01815-w. Mol Cancer. 2023. PMID: 37443114 Free PMC article.
Detecting ALK, ROS1, and RET fusions and the METΔex14 splicing variant in liquid biopsies of non-small-cell lung cancer patients using RNA-based techniques.
Giménez-Capitán A, Sánchez-Herrero E, Robado de Lope L, Aguilar-Hernández A, Sullivan I, Calvo V, Moya-Horno I, Viteri S, Cabrera C, Aguado C, Armiger N, Valarezo J, Mayo-de-Las-Casas C, Reguart N, Rosell R, Provencio M, Romero A, Molina-Vila MA. Giménez-Capitán A, et al. Among authors: sullivan i. Mol Oncol. 2023 Sep;17(9):1884-1897. doi: 10.1002/1878-0261.13468. Epub 2023 Jun 6. Mol Oncol. 2023. PMID: 37243883 Free PMC article.
Epidermolysis bullosa acquisita induced by atezolizumab.
Carmona-Rocha E, Aguado M, Tubau C, Sánchez S, Mozos A, Sullivan I, Spertino J. Carmona-Rocha E, et al. Among authors: sullivan i. J Dtsch Dermatol Ges. 2023 Nov;21(11):1407-1409. doi: 10.1111/ddg.15203. Epub 2023 Sep 1. J Dtsch Dermatol Ges. 2023. PMID: 37658659 No abstract available.
[Epidermolysis bullosa acquisita ausgelöst durch Atezolizumab].
Carmona-Rocha E, Aguado M, Tubau C, Sánchez S, Mozos A, Sullivan I, Spertino J. Carmona-Rocha E, et al. Among authors: sullivan i. J Dtsch Dermatol Ges. 2023 Nov;21(11):1407-1409. doi: 10.1111/ddg.15203_g. J Dtsch Dermatol Ges. 2023. PMID: 37946658 German. No abstract available.
COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical Outcomes.
Bigdelou B, Sepand MR, Najafikhoshnoo S, Negrete JAT, Sharaf M, Ho JQ, Sullivan I, Chauhan P, Etter M, Shekarian T, Liang O, Hutter G, Esfandiarpour R, Zanganeh S. Bigdelou B, et al. Among authors: sullivan i. Front Immunol. 2022 May 27;13:890517. doi: 10.3389/fimmu.2022.890517. eCollection 2022. Front Immunol. 2022. PMID: 35711466 Free PMC article. Review.
184 results